Case Studies

Summary Breast cancer remains one of the most prevalent malignancies worldwide, with an estimated 287,850 new invasive cases and 43,250 breast cancer–related deaths projected in the United States in 2025 (American Cancer Society, 2025). Despite advances in targeted oral therapies for extended adjuvant treatment, real‐world studies find that up to 50% of patients discontinue or…

Summary The cardiovascular pharmaceutical landscape constantly encounters hurdles such as medication non-adherence and fragmented patient engagement. Medisafe’s pioneering digital solutions, including the Medisafe Digital Companion and Medisafe JITI (Just-in-Time-Intervention), offer innovative strategies to enhance patient engagement and drug adherence. This case study focuses on how Medisafe’s digital ecosystem is addressing these challenges, fostering better patient…

Summary This case study examines the unmet needs in treatment adherence and persistence among patients with psoriasis, Crohn’s disease, and ulcerative colitis. Despite advances in biologic therapies, real-world evidence indicates nonadherence rates of up to 50% in psoriasis and 65% in inflammatory bowel disease, driving suboptimal outcomes and increased costs (Smith et al., 2021; Nguyen…